Many patients with CLL are not receiving recommended first-line treatment with BTK inhibitors or BCL2 inhibitors, data suggest. Many patients with CLL are not receiving recommended first-line treatment with BTK inhibitors or BCL2 inhibitors, data suggest.
/PRNewswire/ Integra Connect, LLC., the leading provider of value-based, precision medicine solutions and services for specialty care, today announced.
Integra Connect to Present Key Clinical Research at the ASCO Quality Care Symposium streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.